Disha

Turnaround · United States · 1982–1983

Tylenol 1982: the recall that defined crisis management

After seven people died from cyanide-laced Tylenol capsules, Johnson & Johnson recalled about 31 million bottles nationwide and introduced tamper-proof packaging — and Tylenol recovered most of its market share.

By Shivam Bhandari · Reviewed 31 October 2026 · How we write

by the numbers

Deaths
7
Bottles recalled
about 31 million
Recall cost
about $100 million
Market share, before → low
roughly 35% → about 7%

What happened

In autumn 1982, seven people in the Chicago area died after taking Extra-Strength Tylenol capsules that someone had laced with cyanide after they reached store shelves. Tylenol was America's best-selling painkiller, with roughly a third of the market. The case has never been solved.

J&J did not wait to prove the contamination was local. It warned the public, stopped advertising, and recalled about 31 million bottles across the country at a cost of about $100 million. Executives said they were guided by the company's credo, which put customers first. Market share collapsed to around 7%.

Within weeks J&J relaunched Tylenol in triple-sealed, tamper-resistant packaging, supported by coupons and a large sales effort. Tylenol regained most of its share within about a year, and tamper-evident packaging became an industry and regulatory standard.

Timeline

  1. 1982

    Poisonings in Chicago; nationwide recall (October).

  2. 1982

    Relaunch in tamper-resistant packaging (November).

  3. 1983

    Most market share regained.

what made it work

  • Put public safety ahead of short-term cost.
  • Acted fast and communicated openly.
  • Fixed the vulnerability with a visible product change.

the lesson

In a crisis, acting quickly and visibly in customers' interest — even at great cost — protects the trust that brands depend on.

Apply it to your business

  1. 1Write down what your company will prioritise in a crisis, before one happens.
  2. 2Communicate early, even before you know everything.
  3. 3Show the fix, don't just announce it.

Laws at work in this story

Figures are rounded and drawn from public reports, company filings and widely cited coverage at the time. Check the company's latest filings before relying on any number.

More case studies in Pharma & healthcare products